Callio Therapeutics Launches with $187M Series A for ADC Cancer Therapy

Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, a...

March 04, 2025 | Tuesday | News
Myosin Therapeutics Secures Funding to Advance MT-125 for Glioblastoma, MT-110 for Addiction

 Myosin Therapeutics, Inc., a biotechnology company developing novel therapies for cancer and neurological disorders, has closed its second seed fundi...

March 04, 2025 | Tuesday | News
Nxera Pharma Signs Agreement with Viatris and Idorsia for Cenerimod Development and Commercialization in Japan, South Korea, and APAC

Nxera Pharma has entered an assignment agreement with Viatris Inc. (“Viatris”), a global healthcare company, and Idorsia Pharmaceuticals Ltd (&...

February 28, 2025 | Friday | News
Sarepta Therapeutics Secures $600 Million Senior Secured Revolving Credit Facility to Strengthen Financial Flexibility

Sarepta Therapeutics, Inc. the leader in precision genetic medicine for rare diseases, announced that it has closed on a $600 million senior secu...

February 17, 2025 | Monday | News
BD Announces Strategic Plan to Separate Biosciences and Diagnostic Solutions Business to Unlock Value for Shareholders

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced its board of directors has unanimously authoriz...

February 06, 2025 | Thursday | News
GHIT Fund Announces JPY 2 Billion Investment in New Diagnostics and Drugs for Neglected Tropical Diseases and Malaria

The Global Health Innovative Technology (GHIT) Fund announced a total investment of approximately JPY 2 billion (USD 12.7 million1) in eight...

January 30, 2025 | Thursday | News
Beckman Coulter Life Sciences and Indiana University Secure $2.5M Grant to Boost Leukemia and Lymphoma Testing in Kenya

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, along with the Indiana University School of Medicine, have been a...

January 22, 2025 | Wednesday | News
Ocular Therapeutix Grants Inducement Awards to New Employee Under 2019 Stock Incentive Plan

Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to redefining the retina ex...

January 20, 2025 | Monday | News
Kindeva Drug Delivery Secures $129M Contract to Supply DuoDote® Nerve Agent Antidote to U.S. Strategic National Stockpile

Kindeva Drug Delivery’s global health security division, Meridian Medical Technologies, LLC, secured a contract valued at up to $129 million t...

January 17, 2025 | Friday | News
Silexion Therapeutics Prices Public Offering to Raise $5 Million for RNAi Cancer Therapy Development

Silexion Therapeutics Corp (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA inter...

January 16, 2025 | Thursday | News
Labviva Secures $25 Million Series B to Advance AI-Driven Procurement in Life Sciences

  Labviva, the leading AI procurement platform for life sciences, announced the close of its $25 million Series B, bringing its total funding to ...

January 14, 2025 | Tuesday | News
Andreessen Horowitz (a16z) and Eli Lilly Launch $500 Million Biotech Ecosystem Venture Fund to Drive Healthcare Innovation

Andreessen Horowitz (a16z) Bio + Health  announced a newly formed, first-of-its-kind venture capital fund to fuel broader innovation in human health...

January 13, 2025 | Monday | News
Japan-Based Meiji Seika Pharma Invests $20 Million in U.S.-Based MPM BioImpact to Drive Innovations in Virology and Biotech

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo; President and Representative Director: Daikichiro Kobayashi, hereinafter “Meiji”) announce...

January 13, 2025 | Monday | News
Partner Therapeutics Partners with BARDA to Fund Phase 2 Study of LEUKINE in Sepsis Patients

Partner Therapeutics, Inc. (PTx) announced a collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administrat...

January 10, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close